TScan Therapeutics Inc.
2.65
0.02 (0.76%)
At close: Jan 15, 2025, 3:59 PM
2.65
0.00%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19
PE Ratio -4.29 -0.57 -2.21 -10.06 -19.98
PS Ratio 18.17 2.75 10.61 241.34 n/a
PB Ratio 2.53 0.37 0.67 -6.17 -15.28
P/FCF Ratio -5.93 -0.53 -1.84 -36.06 -19.02
P/OCF Ratio -6.23 -0.56 -2.21 -86.62 -20.91
OCF/S Ratio -2.92 -4.91 -4.8 -2.79 n/a
Debt / Equity Ratio 0.61 0.86 0.04 -0.18 -0.29
Quick Ratio 6.51 6.94 7.76 2.09 17.69
Current Ratio 6.51 6.94 7.76 2.09 17.69
Asset Turnover 0.08 0.07 0.05 0.02 n/a
Interest Coverage -24.86 -56.66 n/a n/a n/a
Return on Equity (ROE) -0.59 -0.66 -0.3 0.61 0.76
Return on Assets (ROA) -0.33 -0.33 -0.26 -0.52 -0.27
Return on Capital (ROIC) -0.39 -0.37 -0.29 -0.81 -0.3
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin -318.8% 62.05% 67.18% -1.80K% n/a
Net Profit Margin -423.86% -486.19% -479.49% -2.40K% n/a
Pretax Profit Margin -423.86% -489.26% -479.49% -2.41K% n/a
Operating Profit Margin -444% -492.32% -479.65% -2.42K% n/a
FCF Margin -306.45% -522.56% -578.03% -669.22% n/a
EBITDA Margin -380.53% -442.62% -446.67% -2.30K% n/a